5432452026-11-12iso4217:INRGLANDGLAND PHARMA LIMITED543245NOTLISTEDINE068V01023Giving of guarantees or indemnity (Sub-para 11-Para B)Newfalse2026-11-1217:00:002026-11-12Giving guaranteesGland Pharma has extended a Corporate Guarantee of EURO 20 Mn in favour of MUFG Bank to secure the draw-down amount and interest thereon availed by Phixen SASfalsePhixen SAS has entered into a Uncommitted Revolving Facility (‘Facility’) Agreement with MUFG Bank (Europe) N.V. (“MUFG Bank”) for Euro 50 Mn with an initial draw-down limit of Euro 18 Mn. Against this initial draw - down Limit, Gland Pharma has extended a Corporate Guarantee of EURO 20 Mn in favour of MUFG Bank to secure the draw-down amount and interest thereon. The Company may extend the Limit of Corporate Guarantee in favour of MUFG Bank, if the draw-down Limits to Phixen SAS increases, in the future. The same will be informed to the Stock Exchanges accordingly. The Facility Agreement is valid for 3 years, and the Corporate Guarantee is valid till March 31, 2030.Phixen SAS has entered into a Uncommitted Revolving Facility (‘Facility’) Agreement with MUFG Bank (Europe) N.V. (“MUFG Bank”) for Euro 50 Mn with an initial draw-down limit of Euro 18 Mn. Against this initial draw - down Limit, Gland Pharma has extended a Corporate Guarantee of EURO 20 Mn in favour of MUFG Bank to secure the draw-down amount and interest thereon. The Company may extend the Limit of Corporate Guarantee in favour of MUFG Bank, if the draw-down Limits to Phixen SAS increases, in the future. The same will be informed to the Stock Exchanges accordingly. The Facility Agreement is valid for 3 years, and the Corporate Guarantee is valid till March 31, 2030.2076838000The Corporate Guarantee will be treated as a contingent liability for the Company. In the event of failure on the part of Phixen SAS in repaying the same to MUFG Bank, the Company has to repay the draw-down amount along with the interest to the MUFG Bank.